Author(s): Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, , Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D,
Abstract Share this page
Abstract Although combination therapy for HIV infection represents a triumph for modern medicine, chronic suppressive therapy is required to contain persistent infection in reservoirs such as latently infected CD4+ lymphocytes and cells of the macrophage-monocyte lineage. Despite its success, chronic suppressive therapy is limited by its cost, the requirement of lifelong adherence, and the unknown effects of long-term treatment. This review discusses our current understanding of suppressive antiretroviral therapy, the latent viral reservoir, and the needs for and challenges of attacking this reservoir to achieve a cure.
This article was published in Science
and referenced in Journal of AIDS & Clinical Research